< Back to previous page
Researcher
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Patrik Verstreken (Flanders Institute for Biotechnology)
Affiliations
- Research Group Molecular Neurobiology (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Responsible
From1 Jan 2008 → Today - Laboratory of Neuronal Communication (VIB-KU Leuven) (Lab)
Member
From1 Jan 2017 → Today - VIB-KU Leuven Center for Brain & Disease Research (Research Center)
Responsible
From1 Jan 2017 → Today - Verstreken Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From1 Apr 2009 → 31 Dec 2016
Projects
41 - 50 of 54
- Infrastructure enabling correlative light and electron microscopy for the Life Sciences.From28 Jun 2012 → 27 Dec 2018Funding: Hercules - Small and Medium size research infrastructure
- The role of deubiquitinases in Parkin-mediated mitophagy and Parkinson's disease.From1 Jan 2012 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
- Molecular mechanisms of synaptic vesicle rejuvenation: Skywalker and epilepsyFrom15 Aug 2011 → 15 Jan 2016Funding: IWT personal funding - strategic basic research grants
- Screens in bacteria and flies new components of the endocytic machinery.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Amyotrophic Lateral Sclerosis and the conservation of Elp3 function from flies to plants.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- LRRK2 signalling pathways: validation and evaluation of the physiologic relevance of candidate substrates for LRRK2 proteinFrom1 Mar 2010 → 28 Feb 2015Funding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying Monosomy 1p36 syndrome as a ciliopathy through exploring the functional role of the ER-Golgi cargoreceptor Rer1p in ciliogenesis in cell models and zebrafish.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- Synaptic dysfunction in Parkinson’s disease and neurodegeneration.From1 Oct 2009 → TodayFunding: BOF - ZAP BOF mandates
- Role of pink1, a Parkinson related gene, in mitochondria and synaptic activity.From1 Oct 2009 → 30 Sep 2015Funding: FWO fellowships
- Molecular studies of neuronal communication in health and disease.From1 Oct 2009 → 30 Sep 2012Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 146
- Neuronal identity defines a-synuclein and tau toxicity(2023)
Authors: Roman Praschberger, Natalie Kaempf, Eliana Nachman, Stein Aerts, Patrik Verstreken
- EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation(2023)
Authors: Marianna Decet, Lily Karamanou, Nikolaos Louros, Tassos Economou, Frederic Rousseau, Joost Schymkowitz, Patrik Verstreken
Pages: 1402 - + - Neurodegeneration cell per cell(2023)
Authors: Sriram Balusu, Bart De Strooper, Patrik Verstreken
Pages: 767 - 786 - Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling(2023)
Authors: Patrick Callaerts, Patrik Verstreken
- Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1(2023)
Authors: Patrik Verstreken
- A reference human induced pluripotent stem cell line for collaborative studies(2022)
Authors: Patrik Verstreken
Pages: 1685 - + - Tau, synapses and brain disease(2022)
Authors: Pablo Largo Barrientos, Patrik Verstreken, Valerie Uytterhoeven
- Nano-positioning and tubulin conformation contribute to axonal transport regulation of mitochondria along microtubules(2022)
Authors: Marianna Decet, Tobie Martens, Patrik Verstreken, Pieter Vanden Berghe
- Do we still need animals? Surveying the role of animal-free models in Alzheimer's and Parkinson's disease research(2022)
Authors: Bart De Strooper, Patrik Verstreken
- Synaptic proteostasis in Parkinson's disease(2022)
Authors: Eliana Nachman, Patrik Verstreken
Pages: 72 - 79
Patents
1 - 10 of 10
- Screening method for synaptogyrin-3 inhibitors (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Means and methods for treatment of early-onset parkinson's disease (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Targeting synaptogyrin-3 in tauopathy treatment (Inventor)
- Compounds for treatment of intractable epilepsy and doors syndrome (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)
- Restoring phosphorylation of a novel pink1 substrate to treat parkinson's disease (Inventor)